Vimarsana
Biggest News Aggregation in the World

Page 9 - Gurufocus Value News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gurufocus Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gurufocus Value Today - Breaking & Trending Today

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares - Vimarsana News

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders, has reported an insider sell transaction.

Source: yahoo.com
Insider Sell: EVP and CEO of Vista, Florian Baumgartner, Sells 4,433 Shares of Cimpress PLC (CMPR) - Vimarsana News

Insider Sell: EVP and CEO of Vista, Florian Baumgartner, Sells 4,433 Shares of Cimpress PLC (CMPR)

Cimpress PLC (NASDAQ:CMPR), a global leader in mass customization, has reported an insider transaction involving Florian Baumgartner, the Executive Vice President and CEO of Vista, a subsidiary of Cimpress.

Source: yahoo.com
Williams-Sonoma Inc CEO Marta Benson Sells Company Shares - Vimarsana News

Williams-Sonoma Inc CEO Marta Benson Sells Company Shares

Marta Benson, CEO of Pottery Barn Brands, a subsidiary of Williams-Sonoma Inc (NYSE:WSM), has sold 17,816 shares of the company on April 4, 2024, according to a recent SEC filing.

Source: yahoo.com
First Solar Inc's Chief Technology Officer Markus Gloeckler Sells Company Shares - Vimarsana News

First Solar Inc's Chief Technology Officer Markus Gloeckler Sells Company Shares

Markus Gloeckler, Chief Technology Officer of First Solar Inc (NASDAQ:FSLR), has sold 1,937 shares of the company on April 4, 2024, according to a recent SEC filing.

Source: yahoo.com
Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares - Vimarsana News

Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares

Certara Inc (NASDAQ:CERT), a global leader in biosimulation, provides software, consulting, and technology-enabled services to support drug discovery, development, and regulatory science.

Source: yahoo.com
Related Topics:
Certara IncGurufocus Value